These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36059516)

  • 1. Identification of cuproptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
    Li Z; Zhang H; Wang X; Wang Q; Xue J; Shi Y; Wang M; Wang G; Zhang J
    Front Immunol; 2022; 13():996836. PubMed ID: 36059516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas.
    Bao JH; Lu WC; Duan H; Ye YQ; Li JB; Liao WT; Li YC; Sun YP
    Front Immunol; 2022; 13():933973. PubMed ID: 36045691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive analysis of cuproptosis-related genes and tumor microenvironment infiltration characterization in breast cancer.
    Song S; Zhang M; Xie P; Wang S; Wang Y
    Front Immunol; 2022; 13():978909. PubMed ID: 36341328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Cuproptosis-Related Subtypes in Lung Cancer, Characterization of Tumor Microenvironment Infiltration, and Establishment of a Prognostic Model.
    Cui J; Xiong Y; Liu Y; Sun M; Gu X; Zhong L; Hong X; Liu L
    Biomed Res Int; 2022; 2022():7406636. PubMed ID: 36588537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive analysis of cuproptosis-related genes in immune infiltration and prognosis in lung adenocarcinoma.
    Xiaona X; Liu Q; Zhou X; Liang R; Yang S; Xu M; Zhao H; Li C; Chen Y; Xueding C
    Comput Biol Med; 2023 May; 158():106831. PubMed ID: 37037146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of cuproptosis-related gene in triple-negative breast cancer.
    Sha S; Si L; Wu X; Chen Y; Xiong H; Xu Y; Liu W; Mei H; Wang T; Li M
    Front Immunol; 2022; 13():922780. PubMed ID: 35979353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis Regulates Microenvironment and Affects Prognosis in Prostate Cancer.
    Li C; Xiao Y; Cao H; Chen Y; Li S; Yin F
    Biol Trace Elem Res; 2024 Jan; 202(1):99-110. PubMed ID: 37155084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of cuproptosis molecular subtype-related signature for predicting immune prognostic characterization in gliomas.
    Huang H; Lv Z; Yang L; Zhang X; Deng Y; Huang Z; Bi H; Sun X; Zhang M; Hu D; Liang H; Hu F
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11499-11515. PubMed ID: 37392200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of cuproptosis-related subtypes in lung adenocarcinoma and its potential significance.
    Pan S; Song C; Meng H; Li N; Li D; Hao B; Lu Z; Geng Q
    Front Pharmacol; 2022; 13():934722. PubMed ID: 36263125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis-Related Signature Predicts the Prognosis, Tumor Microenvironment, and Drug Sensitivity of Hepatocellular Carcinoma.
    Qi X; Guo J; Chen G; Fang C; Hu L; Li J; Zhang C
    J Immunol Res; 2022; 2022():3393027. PubMed ID: 36438201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer.
    Jiang X; Ke J; Jia L; An X; Ma H; Li Z; Yuan W
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):203-218. PubMed ID: 36376617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cuproptosis related subtypes and construction of prognostic signature in gastric cancer.
    Dong H; Zhao S; Zhang C; Wang X
    Front Surg; 2022; 9():991624. PubMed ID: 36684237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of cuproptosis-related genes on bladder cancer prognosis, tumor microenvironment invasion, and drug sensitivity.
    Wang H; Li J; Zi X; Yuan X
    Front Oncol; 2023; 13():1116305. PubMed ID: 36895470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and experimental verification of a prognosis model for cuproptosis-related subtypes in HCC.
    Wang Y; Zhang Y; Wang L; Zhang N; Xu W; Zhou J; Zhao Y; Zhu W; Zhang T; Wang L
    Hepatol Int; 2022 Dec; 16(6):1435-1447. PubMed ID: 36065073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Subtyping Based on Cuproptosis-Related Genes and Characterization of Tumor Microenvironment Infiltration in Kidney Renal Clear Cell Carcinoma.
    Ji ZH; Ren WZ; Wang HQ; Gao W; Yuan B
    Front Oncol; 2022; 12():919083. PubMed ID: 35875087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
    Li J; Yin J; Li W; Wang H; Ni B
    Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of cuproptosis-related subtypes, establishment of a prognostic model and tumor immune landscape in endometrial carcinoma.
    Shan J; Geng R; Zhang Y; Wei J; Liu J; Bai J
    Comput Biol Med; 2022 Oct; 149():105988. PubMed ID: 36007289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Subtypes Based on Cuproptosis-Related Genes and Tumor Microenvironment Infiltration Characterization in Colorectal Cancer.
    Huang H; Long Z; Xie Y; Qin P; Kuang L; Li X; Zhao Y; Zhang X; Yang L; Ma W; Xiao X; Liu Y; Sun X; Zhang M; Wang F; Hu D; Hu F
    J Oncol; 2022; 2022():5034092. PubMed ID: 36276275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.